Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FOLH1 | Q04609 | 7/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.50 |
| ▸ | PLG | P00747 | 1/20 | 0.47 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.47 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.47 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.47 |
| ▸ | TPSAB1 | Q15661 | 1/20 | 0.47 |
| ▸ | CNR1 | P21554 | 2/20 | 0.47 |
| ▸ | CASP3 | P42574 | 2/20 | 0.45 |
| ▸ | CASP1 | P29466 | 1/20 | 0.45 |
| ▸ | CASP2 | P42575 | 1/20 | 0.45 |
| ▸ | CASP7 | P55210 | 1/20 | 0.45 |
| ▸ | CASP8 | Q14790 | 1/20 | 0.45 |
| ▸ | PLCD1 | P51178 | 1/20 | 0.45 |
| ▸ | CAPN1 | P07384 | 2/20 | 0.44 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.43 |
| ▸ | PTPN2 | P17706 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24858269 | 0.93 | TDP1 (0.57) | FOLH1TDP1PLGPRSS1PRSS2 | |
| SCHEMBL24858268 | 0.93 | TDP1 (0.57) | FOLH1TDP1PLGPRSS1PRSS2 | |
| SCHEMBL22580893 | 0.86 | PRSS1 (0.53) | FOLH1TDP1PLGPRSS1PRSS2 | |
| SCHEMBL10172392 | 0.83 | TDP1 (0.64) | FOLH1TDP1CNR1CAPN1 | |
| SCHEMBL29357466 | 0.83 | TDP1 (0.64) | FOLH1TDP1CNR1CAPN1 | |
| SCHEMBL29434690 | 0.83 | TDP1 (0.64) | FOLH1TDP1CNR1CAPN1 | |
| SCHEMBL22580908 | 0.83 | FOLH1 (0.51) | FOLH1TDP1PLGPRSS1PRSS2 | |
| SCHEMBL24858698 | 0.82 | TDP1 (0.48) | FOLH1TDP1PLGPRSS1PRSS2 | |
| SCHEMBL16329737 | 0.82 | FOLH1 (0.62) | FOLH1TDP1PLGPRSS1PRSS2 | |
| SCHEMBL13125727 | 0.81 | PKM (0.57) | FOLH1TDP1PRSS1PRSS2PRSS3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230048956-A1 | BIOTIN MOIETY-CONJUGATED POLYPEPTIDE AND PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION COMPRISING THE SAME | D&D PHARMATECH INC. (KR) | 2023-02-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230048956-A1 | BIOTIN MOIETY-CONJUGATED POLYPEPTIDE AND PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION COMPRISING THE SAME | VIP, BTD, HLCS | FOLH1 558/4885TDP1 4789/4885PLG 1046/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.